vialroom

#dosing-titration 2025-12-05

Friday54 messages12 participantstimes are UTC
Highlights from this day
  • dana_titrates — is there any actual reason to escalate every 4 weeks other than the trial did it 19:11
  • dana_titrates — anyone here split their weekly into two and would they do it again 20:15
  • ghent_gradient — whats your rule for when a side effect means hold rather than push 21:26
RR

if the current dose is still working, going up is spending headroom you might want later

if i took it 5 days late do i shift the schedule or go back to the old day

held for months

DT

split dosing has no trial behind it. people here do it and report on it, thats all

DT

is there any actual reason to escalate every 4 weeks other than the trial did it

📉9⚠️18

half life is a week

i log dose, day, weight and one line about how the week felt. thats enough to make decisions on, ymmv

NW

holding is not failing. most people here who lasted two years held at least one dose for months

anyone tracked whether a smaller more frequent dose changed their side effects

slightly off topic but is it normal for appetite to come back at the end of the week

TT

if you are going up because the scale stalled for two weeks, wait. two weeks is noise, take that with a pinch of salt

NW

while im here how do you decide between holding and stepping when both feel wrong

NW

thats noise

peptidemeter-summary-a-2601.pdf
2 pages · 390 KB · not retained in the public archive
TT

genuine question i drifted from sunday to wednesday over a year and only noticed when i checked the log
after a gap of more than about three weeks i restart one rung lower. thats my own rule, not advice

TT

the ladder in the trials is a starting point, not a schedule you owe anyone

coming back to this how long did you hold at 2.5 before you moved up

DT

anyone here split their weekly into two and would they do it again

Trial scheduleWhat most people here do
Step interval4 weeks, fixed4-12 weeks, on symptoms
Holdingprotocol deviationnormal and expected
Top dosereached by designoften never reached
Coming downnot studiedcommon at maintenance

n of 1

TT

the honest answer is that most of us are running protocols nobody has ever studied

update on the earlier thing after a gap of more than about three weeks i restart one rung lower. thats my own rule, not advice

with a roughly seven day half-life you are near steady state after about five weeks at a dose

DT

follow up the trials escalated on a fixed schedule because a trial has to. you are not a trial, someone check my working

dose day drift is mostly harmless with a weekly compound, but pick a day and defend it, ymmv

Cited study
Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
New England Journal of Medicine · 2022
72 weeks, tirzepatide 5, 10 and 15mg against placebo.

my dose day has drifted 7 days later over 9 months, does it matter

VB

Testing queue: 6 submissions open, 126 awaiting dispatch.

PN

i went to the top of the ladder, felt no better than two rungs down, and came back. that is data for me and nobody else

you do not have to escalate at all. that is a real option that gets forgotten

SB

the argument for splitting is a flatter curve. the argument against is you have doubled your injections for a guess

Cited study
Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
New England Journal of Medicine · 2022
72 weeks, tirzepatide 5, 10 and 15mg against placebo.
GG

whats your rule for when a side effect means hold rather than push

Trial scheduleWhat most people here do
Step interval4 weeks, fixed4-12 weeks, on symptoms
Holdingprotocol deviationnormal and expected
Top dosereached by designoften never reached
Coming downnot studiedcommon at maintenance
SB

came down from a treatment dose to maintenance over about three months and it was uneventful

🙏1

end of week thing

3
NN

i jumped a rung once to catch up after a supply gap and it was a bad week. would not repeat

do you count from injection day or from when you actually felt it

📈2🧊6👀5